INS and type 2 diabetes mellitus: In T2DM, miRNAs target various genes related to glucose and fatty acid metabolism and the insulin signaling pathway in diverse tissues (e.g., skeletal muscle, pancreas, adipocytes, and liver), thereby affecting physiological functions [10, 13, 14].